Tag Archives: AdCom

FDA Advisory Committee Review of 2021

FDA has scheduled the first advisory committee meetings of 2022. One meeting of the Oncologic Drugs Advisory Committee is set for February 10 to discuss a new application for the proposed treatment of Non-Small Cell Lung Cancer (NSCLC. And a … Continue reading

Posted in Advisory Committee Prepapartion | Tagged , | Comments Off on FDA Advisory Committee Review of 2021